控制海马信号的MHC I类抗原处理和呈现途径增强了抗瘤免疫力
Linyuan Peng1, Liang Zhou2, Huan Li2
1State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
Cell reports
|March 25, 2024
概括
阻断Hippo通路 (YAP/TEAD) 通过恢复MHC I类抗原的处理和呈现来增强抗瘤免疫力. 这促进了CD8+T细胞的活性,为癌症免疫治疗提供了一个新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 大型组织相容性复合体I类 (MHC I类) 途径对于抗瘤免疫至关重要,它向CD8+ T细胞呈现抗原.
- 癌症中这种途径的失调阻碍了有效的免疫疗法反应.
研究的目的:
- 调查瘤内在的Hippo途径在调节MHC I类抗原处理和呈现 (APP) 中的作用.
- 探索针对河马通路以增强抗癌免疫力的潜力.
主要方法:
- 对Hippo通路激活与MHC I类APP基因表达和CD8+T细胞透在小鼠和人类瘤中的相关性分析.
- 研究YAP/TEAD复合体与核细胞重塑和脱乙酶复合体相互作用的机制.
- 评估YAP/TEAD抑制对NLRC5转录和MHC I类APP基因表达的影响.
主要成果:
- 瘤内在的Hippo通路激活与MHC I类APP基因表达和CD8+T细胞丰富度正相关.
- 抑制Hippo途径效应者YAP/TEAD显著增强了抗瘤免疫力.
- YAP/TEAD抑制NLRC5的转录;YAP/TEAD的耗尽或抑制可以提高NLRC5的调节,从而促进MHC类I APP和CD8+ T细胞介导的杀死.
结论:
- 通过YAP/TEAD,Hippo通路通过抑制NLRC5,从而促进瘤生长,从而损害MHC类I APP通路.
- 抑制YAP活性是一种有前途的治疗策略,可以提高癌症免疫疗法的疗效.
相关概念视频
Hedgehog Signaling Pathway
7.4K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Antigens Involved in Adaptive Immunity
489
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
489
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


